Neurocysticercosis in the United States

Jose A. Serpa, A. Clinton White

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Neurocysticercosis (NCC) is typically considered a disease of the developing world. Nonetheless, NCC is also diagnosed in the developed world. The rise in the number of cases of NCC in developed countries, especially in the United States of America, has largely been driven by the influx of immigrants from endemic to non-endemic regions and the widespread access to neuroimaging. Cases of local transmission have also been documented particularly in the setting of a tapeworm carrier present in the household, which highlights the relevance of NCC as a public health problem in the USA. Although accurate incidence data in the USA are not available, estimates range from 0.2 to 0.6 cases per 100 000 general population and 1.5-5.8 cases per 100 000 Hispanics. We estimate that between 1320 and 5050 new cases of NCC occur every year in the USA. The number of NCC cases reported in the literature in the USA increased from 1494 prior to 2004 to 4632 after that date. Parenchymal cases remain the most commonly reported form of the disease; however, a slight increase in the percentage of extraparenchymal cases has been described in the most recent series. NCC is associated with significant morbidity resulting from hydrocephalus, cerebral edema, and seizures. Although uncommon, NCC is also a cause of premature death in the USA with a calculated annual age-adjusted mortality rate of at least 0.06 per million population.

Original languageEnglish (US)
Pages (from-to)256-260
Number of pages5
JournalPathogens and Global Health
Volume106
Issue number5
DOIs
StatePublished - 2012

Fingerprint

Neurocysticercosis
Premature Mortality
Cestoda
Brain Edema
Hydrocephalus
Hispanic Americans
Developed Countries
Neuroimaging
Population
Cause of Death
Seizures
Public Health
Morbidity
Mortality
Incidence

Keywords

  • Cysticercosis
  • Hispanics
  • Neurocysticercosis
  • Non-endemic

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Microbiology

Cite this

Neurocysticercosis in the United States. / Serpa, Jose A.; White, A. Clinton.

In: Pathogens and Global Health, Vol. 106, No. 5, 2012, p. 256-260.

Research output: Contribution to journalArticle

Serpa, Jose A. ; White, A. Clinton. / Neurocysticercosis in the United States. In: Pathogens and Global Health. 2012 ; Vol. 106, No. 5. pp. 256-260.
@article{ef07eb545dcf4db6b77575f59651521d,
title = "Neurocysticercosis in the United States",
abstract = "Neurocysticercosis (NCC) is typically considered a disease of the developing world. Nonetheless, NCC is also diagnosed in the developed world. The rise in the number of cases of NCC in developed countries, especially in the United States of America, has largely been driven by the influx of immigrants from endemic to non-endemic regions and the widespread access to neuroimaging. Cases of local transmission have also been documented particularly in the setting of a tapeworm carrier present in the household, which highlights the relevance of NCC as a public health problem in the USA. Although accurate incidence data in the USA are not available, estimates range from 0.2 to 0.6 cases per 100 000 general population and 1.5-5.8 cases per 100 000 Hispanics. We estimate that between 1320 and 5050 new cases of NCC occur every year in the USA. The number of NCC cases reported in the literature in the USA increased from 1494 prior to 2004 to 4632 after that date. Parenchymal cases remain the most commonly reported form of the disease; however, a slight increase in the percentage of extraparenchymal cases has been described in the most recent series. NCC is associated with significant morbidity resulting from hydrocephalus, cerebral edema, and seizures. Although uncommon, NCC is also a cause of premature death in the USA with a calculated annual age-adjusted mortality rate of at least 0.06 per million population.",
keywords = "Cysticercosis, Hispanics, Neurocysticercosis, Non-endemic",
author = "Serpa, {Jose A.} and White, {A. Clinton}",
year = "2012",
doi = "10.1179/2047773212Y.0000000028",
language = "English (US)",
volume = "106",
pages = "256--260",
journal = "Pathogens and Global Health",
issn = "2047-7724",
publisher = "Maney Publishing",
number = "5",

}

TY - JOUR

T1 - Neurocysticercosis in the United States

AU - Serpa, Jose A.

AU - White, A. Clinton

PY - 2012

Y1 - 2012

N2 - Neurocysticercosis (NCC) is typically considered a disease of the developing world. Nonetheless, NCC is also diagnosed in the developed world. The rise in the number of cases of NCC in developed countries, especially in the United States of America, has largely been driven by the influx of immigrants from endemic to non-endemic regions and the widespread access to neuroimaging. Cases of local transmission have also been documented particularly in the setting of a tapeworm carrier present in the household, which highlights the relevance of NCC as a public health problem in the USA. Although accurate incidence data in the USA are not available, estimates range from 0.2 to 0.6 cases per 100 000 general population and 1.5-5.8 cases per 100 000 Hispanics. We estimate that between 1320 and 5050 new cases of NCC occur every year in the USA. The number of NCC cases reported in the literature in the USA increased from 1494 prior to 2004 to 4632 after that date. Parenchymal cases remain the most commonly reported form of the disease; however, a slight increase in the percentage of extraparenchymal cases has been described in the most recent series. NCC is associated with significant morbidity resulting from hydrocephalus, cerebral edema, and seizures. Although uncommon, NCC is also a cause of premature death in the USA with a calculated annual age-adjusted mortality rate of at least 0.06 per million population.

AB - Neurocysticercosis (NCC) is typically considered a disease of the developing world. Nonetheless, NCC is also diagnosed in the developed world. The rise in the number of cases of NCC in developed countries, especially in the United States of America, has largely been driven by the influx of immigrants from endemic to non-endemic regions and the widespread access to neuroimaging. Cases of local transmission have also been documented particularly in the setting of a tapeworm carrier present in the household, which highlights the relevance of NCC as a public health problem in the USA. Although accurate incidence data in the USA are not available, estimates range from 0.2 to 0.6 cases per 100 000 general population and 1.5-5.8 cases per 100 000 Hispanics. We estimate that between 1320 and 5050 new cases of NCC occur every year in the USA. The number of NCC cases reported in the literature in the USA increased from 1494 prior to 2004 to 4632 after that date. Parenchymal cases remain the most commonly reported form of the disease; however, a slight increase in the percentage of extraparenchymal cases has been described in the most recent series. NCC is associated with significant morbidity resulting from hydrocephalus, cerebral edema, and seizures. Although uncommon, NCC is also a cause of premature death in the USA with a calculated annual age-adjusted mortality rate of at least 0.06 per million population.

KW - Cysticercosis

KW - Hispanics

KW - Neurocysticercosis

KW - Non-endemic

UR - http://www.scopus.com/inward/record.url?scp=84874858713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874858713&partnerID=8YFLogxK

U2 - 10.1179/2047773212Y.0000000028

DO - 10.1179/2047773212Y.0000000028

M3 - Article

C2 - 23265549

AN - SCOPUS:84874858713

VL - 106

SP - 256

EP - 260

JO - Pathogens and Global Health

JF - Pathogens and Global Health

SN - 2047-7724

IS - 5

ER -